Company intelligence / Profile preview

Beijing Zhonghui Pharmaceutical

Beijing, Beijing Shi, Chinaen.zhypbz.com ↗

Ownership: Private
Development stage: Commercial

Overview

Beijing Zhonghui Pharmaceutical is a pharmaceutical company based in Beijing, China. It focuses on the development and commercialization of herbal medicines. Its lead and only publicly disclosed product is Wuwei Kushen Enteric-coated Capsule for ulcerative colitis, which has been approved since March 2018 in China. No additional clinical pipeline or results are publicly available as of June 2025.

Therapeutic areas: Gastroenterology
Modalities: Herbal medicineSmall molecule
Industry: Biotech

Drug pipeline

1 asset

Wuwei Kushen

Beyond the preview

Go deeper on Beijing Zhonghui Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beijing Zhonghui Pharmaceutical.

Explore the full profile